We are updating the design of this site. Learn more.
Show more
ClinicalTrials.gov
ClinicalTrials.gov Menu

Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study (CHOICE2)

The recruitment status of this study is unknown. The completion date has passed and the status has not been verified in more than two years.
Verified January 2010 by University of Dundee.
Recruitment status was:  Not yet recruiting
Sponsor:
ClinicalTrials.gov Identifier:
NCT01055210
First Posted: January 25, 2010
Last Update Posted: January 25, 2010
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
Information provided by:
University of Dundee
January 22, 2010
January 25, 2010
January 25, 2010
February 2010
February 2011   (Final data collection date for primary outcome measure)
6 minute hall walk test [ Time Frame: 4 months ]
Same as current
No Changes Posted
Echocardiographic measures of desynchrony [ Time Frame: 3 months ]
Same as current
Not Provided
Not Provided
 
Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study
Optimisation of Cardiac Resynchronisation Therapy by Non-invasive Cardiac Output - The CHOICE2 Study
An evaluation of the role of resting and exercise cardiac output measurement, by the inert gas rebreathing method, in optimisation of patients with cardiac resynchronisation pacemakers.
Not Provided
Interventional
Not Provided
Allocation: Randomized
Intervention Model: Single Group Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
  • Heart Failure
  • Cardiac Resynchronisation Pacemakers
Device: Optimisation of VV delay
Programmed VV delay altered on device
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Unknown status
40
February 2011
February 2011   (Final data collection date for primary outcome measure)

Inclusion Criteria:

  • Cardiac Resynchronization Device in situ for Heart Failure

Exclusion Criteria:

  • Unable to cope with mouthpiece
  • Estimated life expectancy < 6 months
Sexes Eligible for Study: All
18 Years and older   (Adult, Senior)
No
Contact information is only displayed when the study is recruiting subjects
United Kingdom
 
 
NCT01055210
ELD002
No
Not Provided
Not Provided
Dr. Anna Maria Choy, University of Dundee
University of Dundee
Not Provided
Principal Investigator: Anna- Maria Choy University of Dundee
University of Dundee
January 2010

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP